To hear about similar clinical trials, please enter your email below

Trial Title: Immersive Virtual Reality Based Exersice in Post-mastectomy Lymphedema Patients

NCT ID: NCT06553183

Condition: Lymphedema Arm

Conditions: Official terms:
Lymphedema
Breast Cancer Lymphedema

Study type: Interventional

Study phase: N/A

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: Double (Participant, Outcomes Assessor)

Intervention:

Intervention type: Procedure
Intervention name: immersive virtual reality
Description: Exercise based on virtual reality video games. Immersive type will be used.
Arm group label: study group

Intervention type: Procedure
Intervention name: traditional physicaltherapy
Description: pneumatic compression, exercise and skin care
Arm group label: control group
Arm group label: study group

Summary: To determine the effect of immersive virtual reality on shoulder proprioception and ROM of post-mastectomy lymphedema patients.

Detailed description: RESEARCH QUESTION: Does Immersive virtual reality based exercise effective in improving shoulder proprioception and ROM for post-mastectomy patients? Assessment: The digital goniometer will be used in measuring shoulder extension, flexion, adduction, abduction, internal rotation and external rotation before the sessions and after one month of sessions. Also, shoulder proprioception will be assessed by the digital goniometer.The measurement will be taken for both the edematous side and the non-affected side. Treatment: Study group: the patients will receive eight sessions of Immersive virtual reality based exercise, 2 sessions per week for 4 weeks besides the traditional physical therapy. Control group: the patients will receive eight sessions of the traditional physical therapy, 2 sessions per week for 4 weeks.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - All the patients will be females. - Patients with lymph node dissection. - start at least 2 weeks after operation. Exclusion Criteria: - Vision problems. - Medically instable patients. - Balance disorders. - Other musculoskeletal condition of shoulders.

Gender: Female

Minimum age: 35 Years

Maximum age: 65 Years

Healthy volunteers: No

Start date: August 15, 2024

Completion date: February 15, 2025

Lead sponsor:
Agency: Cairo University
Agency class: Other

Source: Cairo University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06553183

Login to your account

Did you forget your password?